Cargando…
CD28 costimulation drives tumor-infiltrating T cell glycolysis to promote inflammation
Metabolic reprogramming dictates the fate and function of stimulated T cells, yet these pathways can be suppressed in T cells in tumor microenvironments. We previously showed that glycolytic and mitochondrial adaptations directly contribute to reducing the effector function of renal cell carcinoma (...
Autores principales: | Beckermann, Kathryn E., Hongo, Rachel, Ye, Xiang, Young, Kirsten, Carbonell, Katie, Healey, Diana C. Contreras, Siska, Peter J., Barone, Sierra, Roe, Caroline E., Smith, Christof C., Vincent, Benjamin G., Mason, Frank M., Irish, Jonathan M., Rathmell, W. Kimryn, Rathmell, Jeffrey C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Clinical Investigation
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7455120/ https://www.ncbi.nlm.nih.gov/pubmed/32814710 http://dx.doi.org/10.1172/jci.insight.138729 |
Ejemplares similares
-
The therapeutic implications of immunosuppressive tumor aerobic glycolysis
por: Reinfeld, Bradley I., et al.
Publicado: (2021) -
Modeling Clear Cell Renal Cell Carcinoma and Therapeutic Implications
por: Wolf, Melissa M., et al.
Publicado: (2020) -
The tumor microenvironment as a metabolic barrier to effector T cells and immunotherapy
por: Lim, Aaron R, et al.
Publicado: (2020) -
Clinical and immunologic correlates of response to PD-1 blockade in a patient with metastatic renal medullary carcinoma
por: Beckermann, Kathryn E., et al.
Publicado: (2017) -
MRI of tumor T cell infiltration in response to checkpoint inhibitor therapy
por: Jiang, Xiaoyu, et al.
Publicado: (2020)